Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.80%14.86M | -37.79%19.86M | -34.19%14.74M | 34.31%31.92M | 119.51%22.4M | -38.97%23.76M | -52.50%10.2M | 31.81%38.94M | 53.06%21.48M | -58.50%29.54M |
| Operating income | 0.80%14.86M | -37.79%19.86M | -34.19%14.74M | 34.31%31.92M | 119.51%22.4M | -38.97%23.76M | -52.50%10.2M | 31.81%38.94M | 53.06%21.48M | -58.50%29.54M |
| Cost of sales | 38.26%-7.39M | 43.22%-14.8M | 34.39%-11.97M | -28.06%-26.06M | -461.66%-18.24M | 27.12%-20.35M | 77.87%-3.25M | -36.22%-27.92M | -48.32%-14.67M | 58.02%-20.5M |
| Operating expenses | 38.26%-7.39M | 43.22%-14.8M | 34.39%-11.97M | -28.06%-26.06M | -461.66%-18.24M | 27.12%-20.35M | 77.87%-3.25M | -36.22%-27.92M | -48.32%-14.67M | 58.02%-20.5M |
| Gross profit | 169.23%7.47M | -13.63%5.06M | -33.29%2.78M | 71.55%5.86M | -40.20%4.16M | -69.02%3.41M | 2.17%6.96M | 21.80%11.02M | 64.37%6.81M | -59.53%9.04M |
| Administrative expenses | -32.99%-6.65M | -6.54%-14.26M | -5.28%-5M | 61.30%-13.38M | 84.28%-4.75M | -95.09%-34.59M | -210.71%-30.23M | 2.33%-17.73M | -56.57%-9.73M | 56.26%-18.15M |
| Revaluation surplus | ---- | 8.20%-6.71M | ---- | 54.79%-7.3M | ---- | -128.98%-16.16M | ---- | ---7.06M | ---- | ---- |
| -Changes in the fair value of investment property | ---- | 8.20%-6.71M | ---- | 54.79%-7.3M | ---- | -128.98%-16.16M | ---- | ---7.06M | ---- | ---- |
| Impairment and provision | ---- | ---5.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.95M |
| -Other impairment is provision | ---- | ---5.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.95M |
| Special items of operating profit | -97.60%6K | -97.06%11K | 216.46%250K | 209.09%374K | -28.18%79K | 23.47%121K | 292.86%110K | 1.03%98K | -76.47%28K | -34.90%97K |
| Operating profit | 141.73%825K | -46.44%-21.17M | -286.13%-1.98M | 69.37%-14.46M | 97.79%-512K | -245.34%-47.21M | -700.83%-23.16M | -14.33%-13.67M | -48.16%-2.89M | 37.07%-11.96M |
| Financing cost | -3.11%-1.49M | 8.50%-2.93M | -15.51%-1.45M | 19.04%-3.2M | 51.92%-1.25M | -1.91%-3.95M | -48.60%-2.6M | -13.22%-3.88M | -4.23%-1.75M | -11.37%-3.43M |
| Adjustment items of earning before tax | ---- | ---- | ---20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 80.68%-665K | -36.48%-24.1M | -95.24%-3.44M | 65.48%-17.66M | 93.16%-1.76M | -191.52%-51.17M | -454.86%-25.76M | -14.09%-17.55M | -27.84%-4.64M | 30.32%-15.38M |
| Tax | 21.08%-131K | 74.81%-234K | 77.32%-166K | -1,964.44%-929K | -285.26%-732K | 19.64%-45K | ---190K | -27.27%-56K | ---- | 98.32%-44K |
| After-tax profit from continuing operations | 77.94%-796K | -30.92%-24.34M | -44.61%-3.61M | 63.70%-18.59M | 90.39%-2.5M | -190.85%-51.21M | -458.95%-25.95M | -14.12%-17.61M | -27.84%-4.64M | 37.52%-15.43M |
| Adjustment items of earning after tax | ---- | ---- | --20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 77.81%-796K | -30.92%-24.34M | -43.81%-3.59M | 63.70%-18.59M | 90.39%-2.5M | -190.85%-51.21M | -458.95%-25.95M | -14.12%-17.61M | -27.84%-4.64M | 47.21%-15.43M |
| Profit attributable to shareholders | 77.81%-796K | -30.92%-24.34M | -43.81%-3.59M | 63.70%-18.59M | 90.39%-2.5M | -190.85%-51.21M | -458.95%-25.95M | -14.12%-17.61M | -27.84%-4.64M | 38.57%-15.43M |
| Basic earnings per share | 78.11%-0.0037 | -30.93%-0.1143 | -44.44%-0.0169 | 63.72%-0.0873 | 90.40%-0.0117 | -190.93%-0.2406 | -459.17%-0.1219 | -14.07%-0.0827 | -27.49%-0.0218 | 38.66%-0.0725 |
| Diluted earnings per share | 78.11%-0.0037 | -30.93%-0.1143 | -44.44%-0.0169 | 63.72%-0.0873 | 90.40%-0.0117 | -190.93%-0.2406 | -459.17%-0.1219 | -14.07%-0.0827 | -27.49%-0.0218 | 38.66%-0.0725 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.